gene therapy

AstraZeneca buys Pfizer’s early gene therapy work for up to $1B
BioPharma Dive
Fri, 07/28/23 - 10:45 am
AstraZeneca
Pfizer
M&A
gene therapy
Gene therapy biotech Kriya adds $150M in fresh funds
BioPharma Dive
Wed, 07/26/23 - 06:35 pm
Kriya Therapeutics
gene therapy
funding
A cancer biotech’s collapse gives Neurogene a path to Wall Street
BioPharma Dive
Tue, 07/18/23 - 10:01 pm
Neurogene
gene therapy
reverse merger
Neoleukin
AbbVie, Lilly-backed Capsida cuts staff months after signing Big Pharma deals
Fierce Biotech
Sun, 07/16/23 - 02:37 pm
Capsida Biotherapeutics
layoffs
gene therapy
AbbVie
Eli Lilly
U.S. watchdog lifts price estimate for Bluebird, Vertex/CRISPR gene therapies to $2.1 million
Reuters
Fri, 07/14/23 - 10:07 am
ICER
gene therapy
Vertex Pharmaceuticals
CRISPR Therapeutics
Bluebird Bio
drug pricing
sickle cell disease
Avrobio stops programs, halves head count and searches for exit
Fierce Biotech
Wed, 07/12/23 - 09:41 am
Avrobio
layoffs
gene therapy
Astellas buys rights to 4D Molecular’s technology in latest gene therapy deal
BioPharma Dive
Mon, 07/10/23 - 09:34 pm
Astellas
4D Molecular Therapeutics
gene therapy
viral vectors
BioMarin's hemophilia gene therapy Roctavian lands FDA nod with 'glimmers' of enthusiasm among doctors
Fierce Pharma
Thu, 06/29/23 - 10:56 pm
BioMarin Pharmaceuticall
Roctavian
FDA
hemophilia A
gene therapy
FDA Approves Sarepta’s Gene Therapy for Duchenne Muscular Dystrophy
BioSpace
Thu, 06/22/23 - 10:51 pm
Sarepta Therapeutics
DMD
Duchenne Muscular Dystrophy
FDA
Elevidys
gene therapy
Uniqure’s accelerated approval hopes take a hit
EP Vantage
Thu, 06/22/23 - 10:07 am
uniQure
Huntington's disease
gene therapy
AMT-130
Bluebird, playing catch-up, gets decision date for sickle cell gene therapy
BioPharma Dive
Wed, 06/21/23 - 11:49 am
Bluebird Bio
gene therapy
sickle cell disease
lovo-cel
FDA
Cell and gene therapy manufacturing: the next generation of startups
BioPharma Dive
Tue, 06/20/23 - 11:28 am
cell therapy
gene therapy
ElevateBio
Ascend Gene & Cell Therapies
Shape Therapeutics
Landmark Bio
Vinta Bio
Vector BioMed
startups
Ferring, with manufacturing update, takes a step towards first gene therapy sales
BioPharma Dive
Wed, 06/14/23 - 10:07 am
Ferring Pharmaceuticals
FDA
bladder cancer
gene therapy
Adstiladrin
Charles River Laboratories, Curigin partner on gene therapy
Pharmaceutical Business Review
Tue, 06/13/23 - 10:41 am
Charles River Laboratories
Curigin
gene therapy
RNA
​Astellas Partners with Kate Therapeutics in Gene Therapy, After Four Patient Deaths in Previous Trials
BioSpace
Thu, 06/8/23 - 09:54 am
Astellas
Kate Therapeutics
gene therapy
X-linked myotubular myopathy
eXmoor pharma raises $35m to boost cell and gene therapy production
Pharmaceutical Business Review
Wed, 05/31/23 - 10:58 am
eXmoor pharma
funding
cell therapy
gene therapy
FDA delays decision on Duchenne gene therapy and considers narrower approval
BioPharma Dive
Wed, 05/24/23 - 11:21 am
Sarepta Therapeutics
FDA
DMD
Duchenne Muscular Dystrophy
gene therapy
ElevateBio Announces $401 Million Series D Financing to Further Accelerate Growth
BioSpace
Wed, 05/24/23 - 10:24 am
ElevateBio
funding
cell therapy
gene therapy
Novartis to buy Avrobio gene therapy for $88M, leaving rest of the biotech on the shelf
Fierce Biotech
Mon, 05/22/23 - 11:35 am
Novartis
gene therapy
Avrobio
AVR-RD-04
Sarepta Enters Uncharted Territory with Adcomm Approval
BioSpace
Mon, 05/22/23 - 10:22 am
Sarepta Therapeutics
SRP-9001
DMD
Duchenne Muscular Dystrophy
FDA
gene therapy

Pages